2005
Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST)
Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST). American Journal Of Obstetrics And Gynecology 2005, 192: 387-393. PMID: 15695976, DOI: 10.1016/j.ajog.2004.08.017.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCognitionDouble-Blind MethodEstradiolFemaleHumansMiddle AgedPostmenopauseStrokeConceptsMini-Mental State ExaminationEstrogen therapyCognitive declineNormal Mini-Mental State ExaminationDouble-blind trialSecondary stroke preventionTransient ischemic attackIschemic attackPostmenopausal womenStroke preventionRecent strokeStroke trialsCerebrovascular diseaseWomen's EstrogenEstradiol-17betaState ExaminationCognitive measuresEstrogenWomenNormal functionDomain measuresLess declineTherapyStrokeRisk
2003
Raloxifene and endothelial function in healthy postmenopausal women
Sarrel PM, Nawaz H, Chan W, Fuchs M, Katz DL. Raloxifene and endothelial function in healthy postmenopausal women. American Journal Of Obstetrics And Gynecology 2003, 188: 304-309. PMID: 12592230, DOI: 10.1067/mob.2003.28.Peer-Reviewed Original ResearchConceptsPostmenopausal womenEndothelial functionPlacebo-controlled crossover trialEndothelial-mediated dilationLaser Doppler measuresEffects of raloxifeneFlow-mediated dilationHealthy postmenopausal womenBrachial artery diameter changesArtery diameter changesWarrants further studyBrachial arteryCardioprotective effectsCrossover trialDoppler measuresCurve ratioHyperemic stimulusRaloxifenePlaceboStimulus intensityDigital vesselsPotential mechanismsRatio of areaWomenFurther studies